Search - tctmd.com

Displaying 101 - 120 of 385

Sort: Relevancy | Date

Presentation TVT 2017

Rationale and Status Update of the EARLY TAVR Trial Asymptomatic Severe AS Patients

Presenter: David J. Cohen, Jeffrey J. Popma, Philippe Généreux

June 16, 2017

Presentation TVT 2017

Rationale and Status Update of the TAVR UNLOAD Trial Moderate AS Patients With Reduced Ejection Fraction

Presenter: David J. Cohen, Jeffrey J. Popma, Nicolas M. Van Mieghem

June 16, 2017

Presentation TVT 2017

A Practical Clinical Algorithm for Correctly Diagnosing and Managing Patients With Low Flow Aortic Stenosis

Presenter: David J. Cohen, Jeffrey J. Popma, Howard C. Herrmann

June 16, 2017

Presentation TVT 2017

A Model of TAVR (vs SAVR) Case Selection, Based Solely on Clinical and Anatomic Factors

Presenter: David J. Cohen, Jeffrey J. Popma, Martin B. Leon

June 16, 2017

Presentation TVT 2017

After PARTNER 2A/S3i and SURTAVI, What Is the Role of Surgery in Intermediate-Risk AS Patients?

Presenter: David J. Cohen, Jeffrey J. Popma, Vinod H. Thourani

June 16, 2017

Presentation TVT 2017

SURTAVI Vignette III: Subset Analysis of Strokes

Presenter: David J. Cohen, Jeffrey J. Popma, A. Pieter Kappetein

June 16, 2017

Presentation TVT 2017

SURTAVI Vignette II: Subset Analysis of Patients With STS < 3% (Lower-Risk Patients)

Presenter: David J. Cohen, Jeffrey J. Popma

June 16, 2017

Presentation TVT 2017

SURTAVI Vignette I: Applying Bayesian Methodology to Interventional Clinical Trials

Presenter: David J. Cohen, Jeffrey J. Popma

June 16, 2017

Presentation TVT 2017

Spotlight Lecture: The SURTAVI LBCT: CoreValve vs Surgery in Intermediate-Risk Aortic Stenosis Patients

Presenter: David J. Cohen, Jeffrey J. Popma, Michael J. Reardon

June 16, 2017

Presentation TVT 2017

TAVR Bioskills & Imaging

Presenter: James M. McCabe

June 16, 2017

Presentation TVT 2017

Endogenous Tissue Restoration: Preclinical Investigation With Bioresorbable, Pulmonary, and Aortic Valves

Presenter: Patrick W. Serruys

June 16, 2017

Presentation TVT 2017

Aortic Root Pseudo-aneurysm Repair With Evolut-R CoreValve

Presenter: Shigeru Saito, Jonathon M. White, Brett Hiendlmayr, MD

June 16, 2017

Presentation TVT 2017

Prevalence of Amyloid in Patients Undergoing TAVR: Low-Flow Phenotype and Echocardiographic Predictors

Presenter: David J. Cohen, Mark J. Russo, Adam Castano

June 16, 2017

Presentation TVT 2017

Percutaneous Transcatheter Aortic Valve Closure to Treat Left Ventricular Assist Device-Associated Aortic Regurgitation

Presenter: Shigeru Saito, Jonathon M. White, Abdullah Alenezi, MD

June 16, 2017

Presentation TVT 2017

The Self-Expanding Single-Operator CENTERA TAVR System

Presenter: Didier Tchetche

June 16, 2017

Presentation TVT 2017

TAVR to Treat Aortic Regurgitation in LVAD Patients Rationale and Case Examples

Presenter: David J. Cohen, Mark J. Russo, Nir Uriel

June 16, 2017

Presentation TVT 2017

Potential Role of Outer Skirt of SAPIEN-3 Valve for Annular Rupture

Presenter: Shigeru Saito, Jonathon M. White, Mike Saji, MD

June 16, 2017

Presentation TVT 2017

The Future Role of Tissue Engineered Aortic Valves for TAVR (and SAVR)

Presenter: A. Pieter Kappetein

June 16, 2017

Presentation TVT 2017

Lotus Aortic Valve Replacement in a Patient With Severe Aortic Valve Calcification: Making a Difference in TAVR

Presenter: Shigeru Saito, Jonathon M. White, Naseer Khan, MD

June 16, 2017

Presentation TVT 2017

Emergent TAVR for AS Patients With Intractable Heart Failure: Feasibility and Early Clinical Results

Presenter: David J. Cohen, Mark J. Russo, Ran Kornowski

June 16, 2017

Advertisement

Rationale and Status Update of the EARLY TAVR Trial Asymptomatic Severe AS Patients

Rationale and Status Update of the TAVR UNLOAD Trial Moderate AS Patients With Reduced Ejection Fraction

A Practical Clinical Algorithm for Correctly Diagnosing and Managing Patients With Low Flow Aortic Stenosis

A Model of TAVR (vs SAVR) Case Selection, Based Solely on Clinical and Anatomic Factors

After PARTNER 2A/S3i and SURTAVI, What Is the Role of Surgery in Intermediate-Risk AS Patients?

SURTAVI Vignette III: Subset Analysis of Strokes

SURTAVI Vignette II: Subset Analysis of Patients With STS < 3% (Lower-Risk Patients)

SURTAVI Vignette I: Applying Bayesian Methodology to Interventional Clinical Trials

Spotlight Lecture: The SURTAVI LBCT: CoreValve vs Surgery in Intermediate-Risk Aortic Stenosis Patients

TAVR Bioskills & Imaging

Endogenous Tissue Restoration: Preclinical Investigation With Bioresorbable, Pulmonary, and Aortic Valves

Aortic Root Pseudo-aneurysm Repair With Evolut-R CoreValve

Prevalence of Amyloid in Patients Undergoing TAVR: Low-Flow Phenotype and Echocardiographic Predictors

Percutaneous Transcatheter Aortic Valve Closure to Treat Left Ventricular Assist Device-Associated Aortic Regurgitation

The Self-Expanding Single-Operator CENTERA TAVR System

TAVR to Treat Aortic Regurgitation in LVAD Patients Rationale and Case Examples

Potential Role of Outer Skirt of SAPIEN-3 Valve for Annular Rupture

The Future Role of Tissue Engineered Aortic Valves for TAVR (and SAVR)

Lotus Aortic Valve Replacement in a Patient With Severe Aortic Valve Calcification: Making a Difference in TAVR

Emergent TAVR for AS Patients With Intractable Heart Failure: Feasibility and Early Clinical Results

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content